Oncology Institute (TOIIW) Current Assets (2019 - 2026)

Oncology Institute (TOIIW) has 8 years of Current Assets data on file, last reported at $116.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 9.4% year-over-year to $116.9 million; the trailing twelve-month figure through Mar 2026 stood at $116.9 million (up 9.4% YoY), and the FY2025 full-year result was $112.7 million, changed 0.29% from the prior year.
• Current Assets for Q1 2026 stood at $116.9 million, up from $112.7 million in the prior quarter.
• Across five years, Current Assets topped out at $152.7 million in Q3 2023 and bottomed at $104.1 million in Q2 2023.
• The 5-year median for Current Assets is $116.4 million (2024), against an average of $122.5 million.
• The widest annual swing landed in 2022, when Current Assets surged 49926.47%; it then slipped 24.34% in 2025.
• A 5-year view of Current Assets shows it stood at $130.4 million in 2022, then increased by 10.03% to $143.5 million in 2023, then fell by 21.66% to $112.4 million in 2024, then rose by 0.29% to $112.7 million in 2025, then grew by 3.65% to $116.9 million in 2026.
• The last three Current Assets figures came in at $116.9 million (Q1 2026), $112.7 million (Q4 2025), and $110.1 million (Q3 2025), per Business Quant data.

Peer Comparison